Canadian Corporate News - Biovail Aware of Second Paragraph IV Certification for Wellbutrin XL.
Thursday, December 11th, 2008 TORONTO, Nov 19, 2004 (CCNMatthews via COMTEX)
Biovail Corporation (NYSE:BVF) (TSX:BVF) has been advised that GlaxoSmithKline (GSK) has received a Notice of Patent Certification associated with an abbreviated new drug application (ANDA) that has been submi…
